AVF Journal Club: Venous Stent Length and Pelvic Stenting

Stent Length Does Not Predict Patency in NIVL or PTS

Among 161 patients, six month patency exceeded 85 percent regardless of whether stents were shorter or longer than 100mm, supporting stenting from normal vein to normal vein and using longer dedicated venous stents to span pelvic curvature safely.

Stent Thrombosis Risk Factors and Technique Pearls

Reduced patency correlated with anticoagulation noncompliance, femoropopliteal inflow disease, iliocaval obstruction, and hypercoagulability; panelists favor IVUS guided sizing, single antiplatelet therapy for nonthrombotic lesions, and brief anticoagulation after thrombotic stenting.

Iliac Vein Stenting for Pelvic Venous Disorders in Young Patients

This controversial disease entity causes chronic pelvic pain, vulvar varicosities, and flank pain from iliac vein stenosis with gonadal reflux; limited retrospective series support stenting alone or combined with ovarian vein embolization, and data beyond two years remain scarce.

Clinical Pearls: Pelvic Sclerotherapy and Referral Patterns

Presenters place the stent first, reserve foam sclerotherapy for persistent varices via transjugular or femoral access with coil embolization on withdrawal, and noted many symptomatic patients are never referred from gynecology to vascular specialists.